These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 25924433)
1. [CecropinA-magainin, a new hybrid antibacterial peptide against meticillin-resistant Staphylococcus aureus]. Yu LM; Yang TT; Wang XQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):218-21. PubMed ID: 25924433 [TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of an antibacterial peptide (cecropinA-magainin) on methicillin-resistant Staphylococcus aureus membranes. Yu L; Zhu M; Liu E; Yang T; Chen X; Wang X Biotechnol Appl Biochem; 2016 Nov; 63(6):805-811. PubMed ID: 26265318 [TBL] [Abstract][Full Text] [Related]
3. Design, recombinant expression, and antibacterial activity of a novel hybrid magainin-thanatin antimicrobial peptide. Tian L; Zhang D; Su P; Wei Y; Wang Z; Wang PX; Dai CJ; Gong GL Prep Biochem Biotechnol; 2019; 49(5):427-434. PubMed ID: 30861356 [TBL] [Abstract][Full Text] [Related]
4. The Antibacterial Effects of Antimicrobial Peptides OP-145 against Clinically Isolated Multi-Resistant Strains. Ming L; Huang JA Jpn J Infect Dis; 2017 Nov; 70(6):601-603. PubMed ID: 28890511 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity against meticillin-resistant Staphylococcus aureus of a novel eukaryotic therapeutic recombinant antimicrobial peptide. Li Q; Huang J; Guo H; Guo X; Zhu Y; Dong K Int J Antimicrob Agents; 2012 Jun; 39(6):496-9. PubMed ID: 22521524 [TBL] [Abstract][Full Text] [Related]
7. Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus. Sarkar P; Acharyya S; Banerjee A; Patra A; Thankamani K; Koley H; Bag PK J Med Microbiol; 2016 Oct; 65(10):1205-1214. PubMed ID: 27553840 [TBL] [Abstract][Full Text] [Related]
8. Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. Meng Y; Hou X; Lei J; Chen M; Cong S; Zhang Y; Ding W; Li G; Li X Pharm Res; 2016 Mar; 33(3):763-75. PubMed ID: 26666773 [TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Dosler S; Mataraci E Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790 [TBL] [Abstract][Full Text] [Related]
10. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms. Yang N; Teng D; Mao R; Hao Y; Wang X; Wang Z; Wang X; Wang J Appl Microbiol Biotechnol; 2019 Jul; 103(13):5193-5213. PubMed ID: 31025073 [TBL] [Abstract][Full Text] [Related]
11. A Temporin Derived Peptide Showing Antibacterial and Antibiofilm Activities against An M; Guo R; Xie S; Wang J; Song Y; Wang R; Jiang W; Wei S; Zhang Y Protein Pept Lett; 2023; 30(2):183-192. PubMed ID: 36476441 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA). Ciandrini E; Morroni G; Arzeni D; Kamysz W; Neubauer D; Kamysz E; Cirioni O; Brescini L; Baffone W; Campana R Curr Top Med Chem; 2018; 18(24):2116-2126. PubMed ID: 30345920 [TBL] [Abstract][Full Text] [Related]
13. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
14. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Smith K; Perez A; Ramage G; Gemmell CG; Lang S Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124 [TBL] [Abstract][Full Text] [Related]
15. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus. Lin MC; Hui CF; Chen JY; Wu JL Peptides; 2013 Jun; 44():139-48. PubMed ID: 23598079 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterisation of a novel antistaphylococcal peptide (ASP-1) from Bacillus sp. URID 12.1. Chalasani AG; Roy U; Nema S Int J Antimicrob Agents; 2018 Jan; 51(1):89-97. PubMed ID: 28887200 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA). Aruldass CA; Masalamany SRL; Venil CK; Ahmad WA Environ Sci Pollut Res Int; 2018 Feb; 25(6):5164-5180. PubMed ID: 28361404 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of novel benzopolycyclic amines. Barniol-Xicota M; Escandell A; Valverde E; Julián E; Torrents E; Vázquez S Bioorg Med Chem; 2015 Jan; 23(2):290-6. PubMed ID: 25515953 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs. Mohamed MF; Hammac GK; Guptill L; Seleem MN PLoS One; 2014; 9(12):e116259. PubMed ID: 25551573 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria. Denardi LB; de Arruda Trindade P; Weiblen C; Ianiski LB; Stibbe PC; Pinto SC; Santurio JM Braz J Microbiol; 2022 Mar; 53(1):171-177. PubMed ID: 34735710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]